Global Drug-Eluting Bioabsorbable Stents Market Research Report 2025(Status and Outlook)

Report Overview

Drug-eluting bioabsorbable stents are medical devices used in the treatment of coronary artery disease. These stents are designed to slowly dissolve over time, reducing the risk of long-term complications associated with traditional metallic stents. The drug-eluting component of these stents helps to prevent restenosis, a condition where the artery narrows again after the stent is implanted. By combining drug delivery with a bioabsorbable material, these stents offer a promising solution for patients requiring coronary artery intervention.

The market for drug-eluting bioabsorbable stents is experiencing significant growth driven by several key factors. One of the primary market drivers is the increasing prevalence of coronary artery disease globally, leading to a higher demand for effective treatment options. Additionally, advancements in stent technology and materials have improved the efficacy and safety profile of drug-eluting bioabsorbable stents, making them a preferred choice for many physicians and patients. Moreover, the growing focus on minimally invasive procedures and the shift towards personalized medicine are further fueling the adoption of these innovative stents in the healthcare industry.

The global Drug-Eluting Bioabsorbable Stents market size was estimated at USD 934.44 million in 2024 and is projected to reach USD 1328.87 million by 2033, exhibiting a CAGR of 4.50% during the forecast period.

This report provides a deep insight into the global Drug-Eluting Bioabsorbable Stents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc. In terms of regional markets, the report details the market space and development potential of each market segment in North America, Europe, Asia Pacific, South America, the Middle East and Africa, as well as the competitive landscape of major players, etc

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug-Eluting Bioabsorbable Stents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug-Eluting Bioabsorbable Stents market in any manner.

Global Drug-Eluting Bioabsorbable Stents Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Medtronic

B.Braun Melsungen

Abbott Laboratories

Boston Scientific Corporation

Biosensors International

Terumo Corporation.

MicroPort Scientific Corporation

Alvimedica

Biotronik

Elixir Medical Corporation

Innovative Health Technologies

Market Segmentation (by Type)

Serolimus and Paclitaxel Drug-Eluting Stents

Sirolimus Drug Eluting Stents

Market Segmentation (by Application)

Coronary Artery Diseases

Peripheral Artery Diseases

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Drug-Eluting Bioabsorbable Stents Market

Overview of the regional outlook of the Drug-Eluting Bioabsorbable Stents Market:

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug-Eluting Bioabsorbable Stents Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Drug-Eluting Bioabsorbable Stents, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Drug-Eluting Bioabsorbable Stents
1.2 Key Market Segments
1.2.1 Drug-Eluting Bioabsorbable Stents Segment by Type
1.2.2 Drug-Eluting Bioabsorbable Stents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Drug-Eluting Bioabsorbable Stents Market Overview
2.1 Global Market Overview
2.1.1 Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Drug-Eluting Bioabsorbable Stents Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Drug-Eluting Bioabsorbable Stents Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Drug-Eluting Bioabsorbable Stents Product Life Cycle
3.3 Global Drug-Eluting Bioabsorbable Stents Sales by Manufacturers (2020-2025)
3.4 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Manufacturers (2020-2025)
3.5 Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drug-Eluting Bioabsorbable Stents Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Drug-Eluting Bioabsorbable Stents Manufacturing Sites, Area Served, Product Type
3.8 Drug-Eluting Bioabsorbable Stents Market Competitive Situation and Trends
3.8.1 Drug-Eluting Bioabsorbable Stents Market Concentration Rate
3.8.2 Global 5 and 10 Largest Drug-Eluting Bioabsorbable Stents Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Drug-Eluting Bioabsorbable Stents Industry Chain Analysis
4.1 Drug-Eluting Bioabsorbable Stents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Drug-Eluting Bioabsorbable Stents Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Drug-Eluting Bioabsorbable Stents Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Drug-Eluting Bioabsorbable Stents Market
5.7 ESG Ratings of Leading Companies
6 Drug-Eluting Bioabsorbable Stents Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2020-2025)
6.3 Global Drug-Eluting Bioabsorbable Stents Market Size Market Share by Type (2020-2025)
6.4 Global Drug-Eluting Bioabsorbable Stents Price by Type (2020-2025)
7 Drug-Eluting Bioabsorbable Stents Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug-Eluting Bioabsorbable Stents Market Sales by Application (2020-2025)
7.3 Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) by Application (2020-2025)
7.4 Global Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2020-2025)
8 Drug-Eluting Bioabsorbable Stents Market Sales by Region
8.1 Global Drug-Eluting Bioabsorbable Stents Sales by Region
8.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Region
8.1.2 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region
8.2 Global Drug-Eluting Bioabsorbable Stents Market Size by Region
8.2.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Region
8.2.2 Global Drug-Eluting Bioabsorbable Stents Market Size Market Share by Region
8.3 North America
8.3.1 North America Drug-Eluting Bioabsorbable Stents Sales by Country
8.3.2 North America Drug-Eluting Bioabsorbable Stents Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Country
8.4.2 Europe Drug-Eluting Bioabsorbable Stents Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region
8.5.2 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Drug-Eluting Bioabsorbable Stents Sales by Country
8.6.2 South America Drug-Eluting Bioabsorbable Stents Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Region
8.7.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Drug-Eluting Bioabsorbable Stents Market Production by Region
9.1 Global Production of Drug-Eluting Bioabsorbable Stents by Region(2020-2025)
9.2 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2020-2025)
9.3 Global Drug-Eluting Bioabsorbable Stents Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Drug-Eluting Bioabsorbable Stents Production
9.4.1 North America Drug-Eluting Bioabsorbable Stents Production Growth Rate (2020-2025)
9.4.2 North America Drug-Eluting Bioabsorbable Stents Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Drug-Eluting Bioabsorbable Stents Production
9.5.1 Europe Drug-Eluting Bioabsorbable Stents Production Growth Rate (2020-2025)
9.5.2 Europe Drug-Eluting Bioabsorbable Stents Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Drug-Eluting Bioabsorbable Stents Production (2020-2025)
9.6.1 Japan Drug-Eluting Bioabsorbable Stents Production Growth Rate (2020-2025)
9.6.2 Japan Drug-Eluting Bioabsorbable Stents Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Drug-Eluting Bioabsorbable Stents Production (2020-2025)
9.7.1 China Drug-Eluting Bioabsorbable Stents Production Growth Rate (2020-2025)
9.7.2 China Drug-Eluting Bioabsorbable Stents Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Medtronic
10.1.1 Medtronic Basic Information
10.1.2 Medtronic Drug-Eluting Bioabsorbable Stents Product Overview
10.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Product Market Performance
10.1.4 Medtronic Business Overview
10.1.5 Medtronic SWOT Analysis
10.1.6 Medtronic Recent Developments
10.2 B.Braun Melsungen
10.2.1 B.Braun Melsungen Basic Information
10.2.2 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Overview
10.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Market Performance
10.2.4 B.Braun Melsungen Business Overview
10.2.5 B.Braun Melsungen SWOT Analysis
10.2.6 B.Braun Melsungen Recent Developments
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Basic Information
10.3.2 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Overview
10.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Market Performance
10.3.4 Abbott Laboratories Business Overview
10.3.5 Abbott Laboratories SWOT Analysis
10.3.6 Abbott Laboratories Recent Developments
10.4 Boston Scientific Corporation
10.4.1 Boston Scientific Corporation Basic Information
10.4.2 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
10.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Market Performance
10.4.4 Boston Scientific Corporation Business Overview
10.4.5 Boston Scientific Corporation Recent Developments
10.5 Biosensors International
10.5.1 Biosensors International Basic Information
10.5.2 Biosensors International Drug-Eluting Bioabsorbable Stents Product Overview
10.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Product Market Performance
10.5.4 Biosensors International Business Overview
10.5.5 Biosensors International Recent Developments
10.6 Terumo Corporation.
10.6.1 Terumo Corporation. Basic Information
10.6.2 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Overview
10.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Market Performance
10.6.4 Terumo Corporation. Business Overview
10.6.5 Terumo Corporation. Recent Developments
10.7 MicroPort Scientific Corporation
10.7.1 MicroPort Scientific Corporation Basic Information
10.7.2 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
10.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Market Performance
10.7.4 MicroPort Scientific Corporation Business Overview
10.7.5 MicroPort Scientific Corporation Recent Developments
10.8 Alvimedica
10.8.1 Alvimedica Basic Information
10.8.2 Alvimedica Drug-Eluting Bioabsorbable Stents Product Overview
10.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Product Market Performance
10.8.4 Alvimedica Business Overview
10.8.5 Alvimedica Recent Developments
10.9 Biotronik
10.9.1 Biotronik Basic Information
10.9.2 Biotronik Drug-Eluting Bioabsorbable Stents Product Overview
10.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Product Market Performance
10.9.4 Biotronik Business Overview
10.9.5 Biotronik Recent Developments
10.10 Elixir Medical Corporation
10.10.1 Elixir Medical Corporation Basic Information
10.10.2 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Overview
10.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Market Performance
10.10.4 Elixir Medical Corporation Business Overview
10.10.5 Elixir Medical Corporation Recent Developments
10.11 Innovative Health Technologies
10.11.1 Innovative Health Technologies Basic Information
10.11.2 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Overview
10.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Market Performance
10.11.4 Innovative Health Technologies Business Overview
10.11.5 Innovative Health Technologies Recent Developments
11 Drug-Eluting Bioabsorbable Stents Market Forecast by Region
11.1 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast
11.2 Global Drug-Eluting Bioabsorbable Stents Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country
11.2.3 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region
11.2.4 South America Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Drug-Eluting Bioabsorbable Stents by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Drug-Eluting Bioabsorbable Stents Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Drug-Eluting Bioabsorbable Stents by Type (2026-2033)
12.1.2 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Drug-Eluting Bioabsorbable Stents by Type (2026-2033)
12.2 Global Drug-Eluting Bioabsorbable Stents Market Forecast by Application (2026-2033)
12.2.1 Global Drug-Eluting Bioabsorbable Stents Sales (K Units) Forecast by Application
12.2.2 Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings